Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.1 SEK | -.--% | +4.99% | -9.98% |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 | |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 |
Sales 2024 * | 584M 52.99M | Sales 2025 * | 624M 56.62M | Capitalization | 392M 35.57M |
---|---|---|---|---|---|
Net income 2024 * | 26M 2.36M | Net income 2025 * | 40M 3.63M | EV / Sales 2024 * | 0.8 x |
Net Debt 2024 * | 77.93M 7.07M | Net Debt 2025 * | 75.63M 6.86M | EV / Sales 2025 * | 0.75 x |
P/E ratio 2024 * |
14.6
x | P/E ratio 2025 * |
9.66
x | Employees | 228 |
Yield 2024 * |
2.03% | Yield 2025 * |
3.42% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 week | +4.99% | ||
Current month | +1.71% | ||
1 month | +1.71% | ||
3 months | -12.02% | ||
6 months | +11.60% | ||
Current year | -9.98% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | Dec. 31 |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 20-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 10.1 | -.--% | 1,616 |
24-04-29 | 10.1 | +3.06% | 63,477 |
24-04-26 | 9.8 | +4.03% | 39,281 |
24-04-25 | 9.42 | -1.46% | 19,433 |
24-04-24 | 9.56 | -1.44% | 1,521 |
Delayed Quote Nasdaq Stockholm, April 30, 2024 at 06:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.98% | 35.71M | |
+7.15% | 217B | |
+6.60% | 183B | |
+9.86% | 131B | |
+24.32% | 106B | |
-0.95% | 62.16B | |
+11.04% | 51.02B | |
+4.81% | 50.89B | |
-1.43% | 40.16B | |
+24.40% | 31.44B |
- Stock Market
- Equities
- BOUL Stock